Suvarna Alladi1, Vladimir Hachinski2. 1. From the Department of Neurology (S.A.), National Institute of Mental Health and Neurosciences, Bengaluru, India; and Department of Clinical Neurological Sciences (V.H.), University of Western Ontario, London, Canada. 2. From the Department of Neurology (S.A.), National Institute of Mental Health and Neurosciences, Bengaluru, India; and Department of Clinical Neurological Sciences (V.H.), University of Western Ontario, London, Canada. Vladimir.hachinski@lhsc.on.ca.
Abstract
OBJECTIVE: To highlight the broad global diversity in the diagnosis, management, and research of dementia in different regions of the world. METHODS: A critical review of the limited literature from the global South compared with advances that have emerged from key studies in the West and observations from the authors' experiences. RESULTS: The last several decades have witnessed major advances in dementia research and include an understanding of epidemiologic trends in the global burden of disease, the development of biomarkers for Alzheimer disease, the identification of novel therapeutic targets, and the recognition of the role of protective life-course experiential factors. For the effective translation of these research advances into societies, a "world approach" to dementia is vital. Developing societies substantially differ from Western countries in their attitudes toward dementia, as well as their clinical manifestations and risk factor profiles, marked by lower education and socioeconomic status, a higher cardiovascular disease burden, and genetic variability. Emerging evidence emphasizes the interaction among ethnicity, genetics, epigenetics, environment, culture, and neurobiology in influencing manifestations of dementia. Therefore, the investigation of dementia in diverse settings, including a more global perspective, is crucial for a comprehensive understanding of the condition as well as the identification of novel solutions. CONCLUSIONS: A world approach to dementia provides an opportunity to understand, manage, coordinate, and begin to prevent dementia through an integrated approach based on firm scientific evidence.
OBJECTIVE: To highlight the broad global diversity in the diagnosis, management, and research of dementia in different regions of the world. METHODS: A critical review of the limited literature from the global South compared with advances that have emerged from key studies in the West and observations from the authors' experiences. RESULTS: The last several decades have witnessed major advances in dementia research and include an understanding of epidemiologic trends in the global burden of disease, the development of biomarkers for Alzheimer disease, the identification of novel therapeutic targets, and the recognition of the role of protective life-course experiential factors. For the effective translation of these research advances into societies, a "world approach" to dementia is vital. Developing societies substantially differ from Western countries in their attitudes toward dementia, as well as their clinical manifestations and risk factor profiles, marked by lower education and socioeconomic status, a higher cardiovascular disease burden, and genetic variability. Emerging evidence emphasizes the interaction among ethnicity, genetics, epigenetics, environment, culture, and neurobiology in influencing manifestations of dementia. Therefore, the investigation of dementia in diverse settings, including a more global perspective, is crucial for a comprehensive understanding of the condition as well as the identification of novel solutions. CONCLUSIONS: A world approach to dementia provides an opportunity to understand, manage, coordinate, and begin to prevent dementia through an integrated approach based on firm scientific evidence.
Authors: Vladimir Hachinski; Karl Einhäupl; Detlev Ganten; Suvarna Alladi; Carol Brayne; Blossom C M Stephan; Melanie D Sweeney; Berislav Zlokovic; Yasser Iturria-Medina; Costantino Iadecola; Nozomi Nishimura; Chris B Schaffer; Shawn N Whitehead; Sandra E Black; Leif Østergaard; Joanna Wardlaw; Steven Greenberg; Leif Friberg; Bo Norrving; Brian Rowe; Yves Joanette; Werner Hacke; Lewis Kuller; Martin Dichgans; Matthias Endres; Zaven S Khachaturian Journal: Alzheimers Dement Date: 2019-07 Impact factor: 21.566
Authors: Elisa Canu; Federica Agosta; Giovanni Battistella; Edoardo G Spinelli; Jessica DeLeon; Ariane E Welch; Maria Luisa Mandelli; H Isabel Hubbard; Andrea Moro; Giuseppe Magnani; Stefano F Cappa; Bruce L Miller; Massimo Filippi; Maria Luisa Gorno-Tempini Journal: Neurology Date: 2020-01-10 Impact factor: 9.910
Authors: Claudia Duran-Aniotz; Paulina Orellana; Tomas Leon Rodriguez; Fernando Henriquez; Victoria Cabello; María F Aguirre-Pinto; Tamara Escobedo; Leonel T Takada; Stefanie D Pina-Escudero; Oscar Lopez; Jennifer S Yokoyama; Agustin Ibanez; Mario A Parra; Andrea Slachevsky Journal: Front Neurol Date: 2021-06-24 Impact factor: 4.003
Authors: Elena Tsoy; Alissa Bernstein Sideman; Stefanie D Piña Escudero; Maritza Pintado-Caipa; Suchanan Kanjanapong; Tala Al-Rousan; Lingani Mbakile-Mahlanza; Maira Okada de Oliveira; Myriam De la Cruz Puebla; Stelios Zygouris; Aya Ashour Mohamed; Hany Ibrahim; Collette A Goode; Bruce L Miller; Victor Valcour; Katherine L Possin Journal: J Alzheimers Dis Date: 2021 Impact factor: 4.160